The Government of the Kyrgyz Republic has taken measures to provide the population with medicines and medical devices in connection with the pandemic of coronavirus infection
Aidar Oruzbaev, lawyer of Bishkek office of Grata International leading pharmaceutical law practice in the Kyrgyz Republic breaks down the main features of newly adopted Decree of the Kyrgyz Government on measures concerning prevention of further spread of COVID-19.
Legal review of the main developments in the pharmaceuticals regulations of Kazakhstan
The new rules for regulating the prices of medicines ('Price Regulation Rules 2019') were adopted in April 2019. Over the past five years, this is the third regulatory legal act establishing the procedure for regulating the prices of medicines.
Regulation Of The Pharmaceutical Industry In Uzbekistan
Currently, the pharmaceutical industry in Uzbekistan is experiencing a modification of regulatory requirements. In recent years, the country has achieved positive results in the formation and development of the primary health care system for population.
Guidelines for the selection of trade names of medicines and for manufacturing of finished dosage forms in the Eurasian Economic Union
The Board of the Eurasian Economic Commission (EEC) approved on 29 January 2019 the Recommendations on the Guidelines for the Selection of Trade Names of Medicinal Products and the Guidelines for Manufacturing of Finished Dosage Forms of Medicinal Products in order to eliminate differences in the requirements for the manufacturing of finished dosage forms of medicines in Eurasian Member States Economic Union (EAEU).
Changes in the regulation of medicines circulation in Russia in 2019
This review highlights some significant changes in federal laws and other regulatory legal acts in Russia that regulate the circulation of medicines.
Changes in the procedure for admission of foreign medical devices and medicines to public procurement in Russia
On 1 January 2019, amendments to the Resolution of the Government of the Russian Federation No. 102 of 05.02.2015 that provides for restrictions and conditions for the admission of certain types of medical devices originating from foreign countries for the purpose of procurement for state and municipal needs ("Resolution No. 102") and the Resolution of the Government of the Russian Federation dated November 30, 2015 No. 1289 that establishes the restrictions and conditions for admission for the purposes of procurement to ensure the state and municipal needs of medicinal products originating from foreign countries included in the list of vital and essential drugs (VED) ("Resolution No. 1289"), came into force.
Registration of Medical Devices in Russia: Recent Changes
The Government of the Russian Federation by its Resolution No. 633, dated 31 May 2018 introduced changes to the Rules for the State Registration of Medical Devices approved by Resolution of the Government No. 1416, dated 27 December 2012 (hereinafter - the 'Registration Rules').
Common market of medicines in the Eurasian Economic Union: clinical trials
On 17 July 2018, the Board of the Eurasian Economic Commission (EEС) adopted the following acts aimed at regulation of the general market of medicines in the Eurasian Economic Union (EAEU)
Simplification of the procedure for state registration of medicines in Russia
On 17 May 2018, amendments to the Federal Law 'On the Circulation of Medicines' (hereinafter - the 'Draft Law'), which simplify the procedure for registration of medicinal products for foreign manufacturers of medicines, were adopted in the third final reading.
New support measures for manufacturers of medicinal products in Russia
Resolution of the Government of the Russian Federation No. 572 dated 12 May 2018 introduced amendments to Resolution No. 1289 dated 30 November 2015 that establishes restrictions and conditions for admission to the procurement for state and municipal need of medicinal products included in the list vital and essential medicines (VEM) originating from foreign states.
Registration of medicines in the Eurasian Economic Union
At the Pharmaceutical Forum of the EAEU and CIS countries held in Moscow in late February 2018, the Director of the Department of Technical Regulation and Accreditation of the Eurasian Economic Commission (EEС) said that the full-scale work on registration of medicines using the unified information system of the Eurasian Economic Union (EAEU) will start upon its launch scheduled on the first half of 2018. Currently, the integration segment of this system is ready, and the work to prepare national segments in each state of the EAEU is underway.